NOT-FD-23-001: Notice to update Section III - Eligibility Information for RFA-FD-23-004-Centers of Excellence in Regulatory Science and Innovation (CERSI) (U01) Clinical Trials Optional

Notice to update Section III - Eligibility Information for RFA-FD-23-004-Centers of Excellence in Regulatory Science and Innovation (CERSI) (U01) Clinical Trials Optional

Notice Number:

NOT-FD-23-001

Key Dates

Release Date:

November 9, 2022

Related Announcements

RFA-FD-23-004 - Centers of Excellence in Regulatory Science and Innovation (CERSI) (U01) Clinical Trials Optional

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this Notice is to update Section III - Eligibility Information

3. Additional Information on Eligibility

Number of Applications

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed. Institutions interested in involving multiple offices/departments (within their institution) should internally coordinate and choose one (1) entity to apply.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Shashi Malhotra

Grants Management Specialist

Office of Operations, Office of Finance Budget & Acquisitions

Office of Acquisitions and Grant Services, HFA-500

U.S. Food and Drug Administration

Tel: 301-402-7592

Shashi.Malhotra@fda.hhs.gov